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Voltage-gated calcium channel auxiliary a2d sub-
units are important for channel trafficking and func-
tion. Here, we compare the effects of a2d-1 and an
a2d-like protein called Cachd1 on neuronal N-type
(CaV2.2) channels, which are important in neuro-
transmission. Previous structural studies show the
a2d-1 VWA domain interacting with the first loop in
CaV1.1 domain-I via its metal ion-dependent adhe-
sion site (MIDAS) motif and additional Cache domain
interactions. Cachd1 has a disrupted MIDAS motif.
However, Cachd1 increases CaV2.2 currents sub-
stantially (although less than a2d-1) and increases
CaV2.2 cell surface expression by reducing endocy-
tosis. Although the effects of a2d-1 are abolished
bymutation of Asp122 in CaV2.2 domain-I, whichme-
diates interaction with its VWA domain, the Cachd1
responses are unaffected. Furthermore, Cachd1 co-
immunoprecipitates with CaV2.2 and inhibits co-
immunoprecipitation of a2d-1 by CaV2.2. Cachd1
also competes with a2d-1 for effects on trafficking.
Thus, Cachd1 influences both CaV2.2 trafficking
and function and can inhibit responses to a2d-1.
INTRODUCTION
Voltage-gated calcium (CaV) channels are key constituents of
excitable cells, including muscles, neurons, and secretory cells,
and are essential for their function (for a review, see Zamponi
et al., 2015). The neuronal N-type (CaV2.2) and P/Q-type
(CaV2.1) channels are critical for presynaptic release of neuro-
transmitters (for a review, see Nanou and Catterall, 2018), with
N-type calcium channels playing a particularly important role in
primary afferent neurotransmission involving pain pathways
(for a review, seeMcGivern andMcDonough, 2004). CaV a1 sub-
units form the pore of the channels, determining their main bio-
physical and pharmacological properties (Zamponi et al.,
2015), but the associated b and a2d proteins represent auxiliary1610 Cell Reports 25, 1610–1621, November 6, 2018 ª 2018 The Au
This is an open access article under the CC BY license (http://creativesubunits that are important contributors to the trafficking and
biophysical properties of the channel complexes (Gurnett
et al., 1996; Leung et al., 1987; Pragnell et al., 1994; Takahashi
et al., 1987). The b subunits increase CaV currents by binding
to the intracellular I-II linker (Pragnell et al., 1994), promoting
folding (Van Petegem et al., 2004), hyperpolarizing current acti-
vation (Stea et al., 1993), preventing polyubiquitination (Page
et al., 2016), and inhibiting proteasomal degradation (Altier
et al., 2011; Waithe et al., 2011).
By contrast, the mechanism by which the a2d subunits in-
crease trafficking and function of channel complexes is less
well understood (Cantı´ et al., 2005; Cassidy et al., 2014; Ferron
et al., 2018; Kadurin et al., 2016; Savalli et al., 2016). The a2d-1
subunit, in combination with neuronal calcium channels, is the
therapeutic target for gabapentinoid drugs, used for the allevia-
tion of neuropathic pain conditions and as an add-on therapy in
certain epilepsies (Field et al., 2006), and it is therefore important
to understand its mechanism of action. The a2d proteins undergo
several post-translational processing steps, including N-glyco-
sylation, proteolytic cleavage into a2 and d (De Jongh et al.,
1990; Ellis et al., 1988; Jay et al., 1991), and glycosyl-phospha-
tidylinositol (GPI) anchoring (Davies et al., 2010).
The recent structure of the skeletal muscle CaV1.1 complex
(Wu et al., 2016) has revealed a complex interaction of a2d-1
with several extracellular loops in domains I-III of CaV1.1. In the
present study, we have taken advantage of the insights provided
by this structure to probe the role of the von Willebrand factor
A (VWA) domain and investigate whether there is a role for other
a2d domains in CaV channel function. In previous studies, by
mutating the metal ion-dependent adhesion site (MIDAS) motif
in the VWA domain of a2d subunits, we have shown that the
VWA domains of both a2d-1 and a2d-2 are key to promoting cal-
cium channel trafficking and function (Cantı´ et al., 2005; Cassidy
et al., 2014; Hoppa et al., 2012). The structure confirms the inter-
action of the MIDAS motif with the CaV1.1 a1 subunit (Wu et al.,
2016). However, we also found that mutating the MIDAS motif
reduced the trafficking of a2d-1 itself when it was expressed
alone (Cassidy et al., 2014). In the present study, we have there-
fore taken the reciprocal step of mutating the residue in CaV2.2
with which a2d-1 is predicted to bind to examine whether other
regions, such as their Cache domains, play a role in promotingthors.
commons.org/licenses/by/4.0/).
CaV2.2 trafficking and function. The Cache domains in a2d-1,
which have homology to domains in bacterial chemotaxis recep-
tors (Anantharaman and Aravind, 2000), have also been shown
to interact with the CaV1.1 a1 subunit (Wu et al., 2016). We
have compared the effect of a2d-1 with that of Cachd1, identified
bioinformatically to be related to a2d proteins (Whittaker and Hy-
nes, 2002). Cachd1 has a VWA domain with a disrupted MIDAS
motif but retains multiple predicted Cache domains. Surpris-
ingly, we found that expression of Cachd1 increased both
CaV2.2 currents and cell surface trafficking in both cell lines
and neurons. By contrast, expression of Cachd1 did not increase
the closely related CaV2.1 currents, indicating that this effect
shows specificity for certain calcium channels. Furthermore,
Cachd1 competed with a2d-1 for binding to CaV2.2 and for its
functional effects and can therefore inhibit responses to a2d-1.
RESULTS
Disruption of the Interaction Site between CaV2.2 and
the a2d-1 VWA Domain Prevents the Interaction
between a2d-1 and CaV2.2
In previous studies, we found that mutation of theMIDASmotif in
a2d-1 and a2d-2 prevented the ability of these proteins to traffic
CaV2 channels and abolished the increase in CaV1 and CaV2 cur-
rents, normally seen with wild-type (WT) a2d-1 and a2d-2 (Cantı´
et al., 2005; Cassidy et al., 2014; Hoppa et al., 2012). However,
trafficking of the a2d-1 MIDAS mutant alone to the cell surface
was also impaired (Cassidy et al., 2014), and our data indicate
that a2d-1 also interacts with the trafficking protein LRP1 via its
VWA domain (Kadurin et al., 2017). Therefore, in the present
study, we took advantage of the recently described structure
of the skeletal muscle calcium channel complex (Wu et al.,
2016) and mutated the residue in CaV2.2 likely to coordinate
the divalent cation together with the MIDAS interaction site of
a2d-1. The structure of CaV1.1 shows this to be residue D78,
which is in the first extracellular loop of domain I; it corresponds
by alignment to D122 in CaV2.2 (Figures 1A and 1B). This residue
was mutated to uncharged alanine to disrupt the interaction with
a2d-1. D122A CaV2.2 was expressed at the same level as WT
CaV2.2 in tsA-201 cells in the presence of b1b and a2d-1 (Fig-
ure 1C). As we found previously (Kadurin et al., 2016), CaV2.2
showed robust co-immunoprecipitation with a2d-1 (Figures 1C
and 1D). In contrast, D122A CaV2.2 exhibited only very weak
co-immunoprecipitation (coIP) with a2d-1 (Figures 1C and 1D),
confirming a key role for D122 in this interaction.
The a2d Homolog Cachd1 Is Expressed on the Cell
Surface and Interacts with CaV2.2
The cryoelectron microscopy (cryo-EM) structure of CaV1.1
shows that a2d-1 has four Cache domains (Anantharaman and
Aravind, 2000; Wu et al., 2016), and there are interactions of
the a1 subunit with these domains as well as with the VWA
domain (Wu et al., 2016). The a2d-like protein Cachd1 contains
Cache domains, similar to the a2d subunits, but its VWA domain
has a highly disruptedMIDASmotif (Whittaker and Hynes, 2002).
Indeed, in a preliminary report, Cachd1 was found to have no ef-
fect on CaV2.2 currents (Soubrane et al., 2012). Because our ex-
periments also suggest that the VWA domain has a dominantrole in mediating the effects of a2d-1, we decided to investigate
whether Cachd1 showed any residual functional effect on
CaV2.2 function.
We initially used a construct encoding zebrafish Cachd1
(zCachd1) that had been generated in a study to identify genes
underlying particular nervous system development phenotypes
(H. Stickney, A. Faro, G.T.P., and S.W.W., unpublished data).
We subsequently confirmed our results with the rat construct
rCachd1. There is very high sequence conservation, the two pro-
teins being 85.6% identical at the amino acid level. Using a poly-
clonal antibody (Ab) raised against the predicted extracellular
domain of zCachd1, which also recognizes human CACHD1
(G.T.P., G.J. Wright, and S.W.W., unpublished data), we
observed a major band of the predicted molecular weight
(MW) in whole-cell lysate (WCL) of tsA-201 cells transfected to
express either zCachd1 or rCachd1 (Figure 1E). Cachd1 is pre-
dicted to be an N-glycosylated protein (Figure S1A). For
rCachd1, the MW was 168 kDa when glycosylated and
148 kDa following deglycosylation with N-Glycosidase F
(PNGase F), indicating that it has up to 7 N-glycosylation sites
(Figure 1E), agreeing with the predicted number (Figure S1A).
The glycosylation pattern is also compatible with the prediction
that Cachd1 is a type I membrane protein (Figure S1A), in
contrast to the GPI-anchored a2d proteins (Davies et al., 2010).
In addition to the major Cachd1 protein band, two lower MWmi-
nor bands were observed. For rCachd1, these were 148 and
137 kDa, reduced to133 and119 kDa following deglycosy-
lation (Figure 1E). Similar results were found for zCachd1 (Fig-
ure 1E). Cell surface biotinylation indicated that the major band
was the species on the plasma membrane (Figure 1E), suggest-
ing that membrane-associated Cachd1 does not undergo post-
translational proteolytic processing, unlike a2d proteins.
To determine whether Cachd1 was co-localized on the cell
surface with CaV2.2, we expressed the proteins in N2A or tsA-
201 cells and imaged their localization. We found that both
rCachd1 (Figure 1F) and zCachd1 (Figure S1B) were present
on the cell surface, together with either WT CaV2.2 or D122A
CaV2.2 and b1b. Partial co-localization of Cachd1 with CaV2.2-
hemagglutinin (HA) on the cell surface was observed (Figure 1F,
yellow regions). Even in permeabilized cells, most of the Cachd1
appeared to be associated with the cell surface (Figure S1B).
We then co-expressed CaV2.2 with a C-terminally GFP-
tagged Cachd1 and found that immunoprecipitation (IP) of
Cachd1_GFPwith GFP Abwas able to coIP CaV2.2. As a control,
there was no coIP of CaV2.2 using Cachd1 without a GFP tag
(Figure 1G), expression of which was confirmed using Cachd1
Ab (Figure S1C). The interaction of Cachd1 with CaV2.2 was
likely to be weaker than that observed for a2d-1 because no
coIP of Cachd1 with GFP_CaV2.2 was observed in experiments
performed under conditions similar to those shown for a2d-1 in
Figure 1C (Figure S1D).
The D122A Mutation in CaV2.2 Prevents the Effect of
a2d-1 but Not Cachd1 on Cav2.2 Currents
In agreement with the coIP results, we found that expression of
rCachd1 produced a consistent increase (4.5-fold) in WT CaV2.2
currents (in the additional presence of b1b) despite its disrupted







Figure 1. Effect of D122AMutation in CaV2.2
on Interaction with a2d-1 and Cachd1
(A) Sequence alignment of the VWA domain
interaction site on CaV1.1 in comparison with the
rabbit CaV2.2 used in this study, showing the po-
sition of D122 in the first extracellular loop of
CaV2.2. Residue numbering is shown (#).
(B) Diagram of the putative CaV2.2 interaction site
with the VWA domain of a2d-1, showing the posi-
tion of the D122Amutation and the HA epitope tag.
(C) IP of GFP_CaV2.2, and co-immunoprecipita-
tion (coIP) of a2d-1. WCL input (left) and IP (right)
for WT and D122A mutant GFP_CaV2.2 and un-
tagged CaV2.2 control (top) and for HA-tagged
a2d-1 (bottom). IPwas performedwithGFP Ab and
pulled down bothWT andD122AGFP_CaV2.2 (top
right). CoIP of HA-tagged a2d-1 is shown in at the
bottom right (arrow).
(D) Quantification of coIP of a2d-1 with WT
GFP_CaV2.2 (solid blue bar) comparedwithD122A
GFP_CaV2.2 (open blue bar) and control CaV2.2
(open black bar); mean ± SEM of 5 experiments.
(E) Western blot using Cachd1 Ab of WCL from
tsA-201 cells transfected with a2d-1 as a control
(lane 1), rCachd1 (lane 2), and zCachd1 (lane 3).
Left: prior to deglycosylation with PNGase F.
Center: after deglycosylation. Bottom: glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH)
loading control. Right: a separate experiment after
cell surface biotinylation and deglycosylation; the
control here was untransfected cells. The arrow
indicates a major Cachd1 band.
(F) Representative confocal images of N2A cells
expressing CaV2.2 HA WT (left) or D122A (right)
with b1b and rCachd1. Cells were not per-
meabilized and incubated with rat anti-HA and
rabbit anti-Cachd1 Abs for 1 hr to show extra-
cellular HA staining on the plasma membrane (top
row, white) and Cachd1 (center row, green).
Merged images (with HA in red and co-localization
in yellow) are shown at the bottom; DAPI was used
to stain the nuclei (blue). Scale bars, 20 mm.
(G) IP of Cachd1_GFP and coIP of CaV2.2. Shown
are WCL input (left) and IP (right). Top: CaV2.2.
Bottom: zCachd1_GFP (left lane) and untagged
zCachd1 (right lane; both lanes are from the same
blot). IP was performed with GFP Ab and pulled
down both Cachd1_GFP (bottom) and CaV2.2 (top
right, arrow). Lack of coIP of CaV2.2 with un-
tagged Cachd1 is shown in the right lane. Data are
representative of n = 6 experiments. zCachd1
expression in WCL is confirmed in Figure S1C.We then examined the effect of the D122A mutation on the
ability of a2d-1 and Cachd1 to increase CaV2.2 currents. We
found that, although a2d-1 increased themaximum conductance
(Gmax) of WT CaV2.2 by 11.5-fold, it produced no increase in the
case of D122A CaV2.2, for which the currents were of the same
amplitude as WT CaV2.2 without a2d (Figures 2A–2C). Very
similar results to those observed with a2d-1 were obtained for
a2d-3 (Figure S2).
By contrast, we found that Cachd1 produced a similar in-
crease (5.2-fold) in Gmax for D122A CaV2.2 to that observed for
WT CaV2.2 (Figures 2A–2C). This result indicates that the effect1612 Cell Reports 25, 1610–1621, November 6, 2018of Cachd1 is unlikely to be dependent on co-ordination of a diva-
lent cation between its disrupted MIDAS motif and loop I of the
a1 subunit and, therefore, might involve other interactions with
Cachd1. Like a2d-1, Cachd1 induced a shift of current activation
to more hyperpolarized potentials for both WT and D122A
CaV2.2, as shown in the current-voltage (I-V) relationships
(Figure 2B).
It is noteworthy that, for both WT CaV2.2 and D122A CaV2.2,
we observed that the barium current (IBa) in the presence of
rCachd1 had an apparent reversal potential that was 11.6 mV






Figure 2. D122A Mutation of CaV2.2 Abol-
ishes CaV2.2 Current Enhancement by
a2d-1 but Not Cachd1
(A) Example families of CaV2.2 currents for WT
CaV2.2-HA (top row) and D122A CaV2.2-HA (bot-
tom row), co-expressed with b1b and either no a2d
(left), a2d-1 (center), or rCachd1 (right). Holding
potential80mV, steps between50 and +60mV
for 50 ms (top, applies to all traces).
(B) Mean (± SEM) current-voltage relationships
for the conditions shown in (A). WT CaV2.2-HA
(solid circles; n = 9, 18, and 27 for no a2d, a2d-1,
and Cachd1, respectively) and D122A CaV2.2-HA
(open circles; n = 10, 11, and 21 for no a2d, a2d-1,
and Cachd1, respectively) were co-expressed
with b1b and either no a2d (blue), a2d-1 (red), or
Cachd1 (green). The individual and mean data
were fit with a modified Boltzmann equation
(STAR Methods). The potential for half-maximal
activation (V50,act) (mV) was +4.9 ± 1.3, 2.9 ±
1.6, and 4.6 ± 0.5 for WT CaV2.2-HA with no
a2d, a2d-1 and Cachd1, respectively, and +4.5 ±
0.7, +3.7 ± 0.9, and 3.6 ± 0.7 for D122A
CaV2.2-HA with no a2d, a2d-1, and Cachd1,
respectively.
(C) Gmax (nanosiemens [nS]/picofarad [pF]) from
the current-voltage relationships shown in (B).
Individual data (same symbols as in B) andmean ±
SEM are plotted. yp = 0.0483, #p = 0.0357,
****p < 0.0001 (1-way ANOVA and Sidak’s post
hoc test correcting for multiple comparisons).
(D) Bar charts of mean ± SEM for reversal poten-
tial (Vrev) (millivolt) for the conditions shown in (B).
WT CaV2.2-HA (solid bars) and D122A CaV2.2-HA
(open bars) were co-expressed with b1b and
either no a2d (blue), a2d-1 (red), or Cachd1 (green).
ns, not significant; ***p < 0.001, ****p < 0.0001
(1-way ANOVA and Sidak’s post hoc test cor-
recting for multiple comparisons).
(E) Examples of current traces at +5 mV of WT
CaV2.2 co-expressed with b1b and either a2d-1
(left) or Cachd1 (right) before (control) and after
application of 1 mM u-conotoxin GVIA (+ u-CTX).
(F) Mean (± SEM) current-voltage relationships
before the application of u-conotoxin GVIA for WT
CaV2.2-HA co-expressed with b1b and either
a2d-1 (red circles, n = 7) or Cachd1 (green circles,
n = 6). The application of u-conotoxin GVIA (1 mM)
produced a complete block of WT CaV2.2 co-ex-
pressed with a2d-1 (red triangles, n = 7) or Cachd1
(green triangles, n = 6).
(G) Mean (± SEM) current-voltage relationships for CaV2.1 co-expressed with b1b and either no a2d (blue solid circles, n = 12), a2d-1 (red solid circles, n = 14),
or Cachd1 (green solid circles, n = 12). The individual and mean data were fit with a modified Boltzmann equation (STAR Methods).presence of a2d-1, suggesting a possible effect of Cachd1 on ion
selectivity (Figure 2D). Under the same recording conditions, no
effect was observed of rCachd1, expressed alone, on endoge-
nous conductances in tsA-201 cells, which might independently
account for this effect on the reversal potential. Furthermore, the
u-conotoxin GVIA (GVIA) completely abolished CaV2.2 currents
when coexpressed with b1b and rCachd1, as it did when b1b
and a2d-1 (Figures 2E and 2F). Note that the negative shift in
reversal potential induced by Cachd1, relative to a2d-1, remains
present in this dataset prior to u-conotoxin GVIA application
(Figure 2F).Surprisingly, rCachd1 did not increase currents through the
related CaV2.1 channel under the same conditions, although
a2d-1 produced the expected effect (Figure 2G; Figures S3A
and S3B), indicating that there is selectivity in the effect of
Cachd1 for specific calcium channel isoforms.
The D122AMutation in CaV2.2 Reduces the Effect of a2d
but Not Cachd1 on CaV2.2 at the Plasma Membrane
We then compared the cell surface expression of WT and D122A
CaV2.2-HA, either in thepresenceor absenceofa2d-1 orCachd1,




Figure 3. D122A Mutation in CaV2.2 Pre-
vents Effect of a2d-1 but Not Cachd1 on
CaV2.2 Cell Surface Expression in N2A Cells
(A and B) Representative confocal images of N2A
cells expressing GFP_CaV2.2-HAWT (A) or D122A
(B) with b1b in the absence of a2d (control, top row)
with a2d-1 (center row) or rCachd1 (bottom row).
Intact cells (non-permeabilized) were incubated
with rat anti-HA Ab for 1 hr to visualize extracellular
HA staining on the plasma membrane (left, white)
to be compared with intracellular GFP fluores-
cence (center). Merged images (with HA in red) are
shown on the right; DAPI was used to stain the
nuclei (blue). Scale bars, 20 mm.
(C and D) Bar charts showing cell surface
expression of WT (closed bars) and D122A
CaV2.2-HA (open bars), determined by HA staining
prior to permeabilization (C), and cytoplasmic
expression determined by GFP fluorescence (D).
Blue bars are for the control condition without a2d
or Cachd1, red bars are with a2d-1, and green bars
are with rCachd1. Data (mean ± SEM) for 164
(WT  a2d-1), 220 (WT + a2d-1), 185 (WT +
Cachd1), 165 (D122A  a2d-1), 203 (D122A +
a2d-1), and 232 (D122A + rCachd1) cells from 3
experiments were normalized to the WT CaV2.2-
HA + a2d-1 condition in each experiment. ***p <
0.001, ****p < 0.0001 (one-wayANOVAandSidak’s
post hoc test correcting for multiple comparisons).
(E) Representative confocal images of N2A cells
expressing CaV2.2-bungarotoxin binding site
(BBS) and labeled with BTX-488. Cells were co-
transfected with b1b and either empty vector
(control, left), a2d-1 (center), or rCachd1 (right).
Cells were incubated at 17C with BTX-488 for
30 min and then imaged at different time points,
from zero (t0) to 40 min (t40). Scale bar, 20 mm.
(F) Time course of endocytosis of cell surface
CaV2.2-BBS in control + b1b alone (blue cir-
cles), + a2d-1 (red squares), and + rCachd1 (green
triangles). BTX-488 fluorescence was normalized
to the mean fluorescence of the + a2d-1 condition
at t0. The results are shown as the mean ± SEM.
The number of cells (n) obtained from 5 inde-
pendent experiments varies from 349 to 789 for
each time point and condition. The data were
fitted with single exponentials. The time constants
of the fits were 8.5 min, 9.9 min, and 15.4 min for
control, + a2d-1, and + rCachd1, respectively.
(G) Bar chart (mean ± SEM) comparing the reduction of cell surface CaV2.2-BBS at 10 min for the 3 conditions. BTX-488 fluorescence was normalized to t0 for
each condition. BTX-488 fluorescence was reduced by 42% ± 3% for control (blue bar, n = 743 cells), 50% ± 2% for + a2d-1 (red bar, n = 646 cells), and 32% ±
2% for + rCachd1 (green bar, n = 784 cells). *p = 0.0109, ****p < 0.0001 (one-way ANOVA and Bonferroni’s post hoc test for multiple comparisons).CaV2.2-HA was N-terminally GFP-tagged to identify all trans-
fected cells. WT CaV2.2-HA was well expressed at the cell sur-
face when co-expressed with a2d-1, which resulted in a 7.3-
fold increase compared with its cell surface expression in the
absence of a2d (Figures 3A and 3C). In contrast, D122A CaV2.2-
HA exhibited a very low expression level at the plasma mem-
brane, which was similar in the presence and absence of a2d-1
(Figures 3B and 3C). In contrast, intracellular expression of WT
or D122A CaV2.2-HA (Figures 3A and 3B) was not significantly
different with and without a2d-1 (Figure 3D).
In the same experiment, we also investigated the effect of
rCachd1 on cell surface expression of CaV2.2-HA. We found1614 Cell Reports 25, 1610–1621, November 6, 2018that it produced an increase of 2.9-fold in cell surface expression
of WT CaV2.2-HA (Figures 3A and 3C). Very similar results were
obtained for zCachd1 in tsA-201 cells (Figures S4A and S4B). Of
great interest, and similar to its effect on calcium currents, is that
rCachd1 increased cell surface expression of D122A CaV2.2-HA
by an extent similar to its effect on WT CaV2.2-HA (a 2.7-fold in-
crease compared with D122A CaV2.2-HA alone; Figures 3B and
3C). Intracellular expression of WT or D122A CaV2.2-HA (Figures
3A and 3B) was not significantly different with or without rCachd1
(Figure 3D).
To understand the mechanism of action of Cachd1, we




Figure 4. D122A Mutation in CaV2.2 Pre-
vents the Effect of a2d-1 on CaV2.2-HA Cell
Surface Expression in Hippocampal Neu-
rites and Somata
(A) Representative confocal images showing neu-
rites of hippocampal neurons expressing CaV2.2-
HA WT together with b1b and mCherry in the
presence (top row) or absence (bottom row) of
a2d-1. Expression of mCherry is shown in red (left).
Cav2.2-HA (green, center) was stained using rat
anti-HA Ab prior to permeabilization, and the rabbit
II-III loop Ab (white, right) after permeabilization.
DAPI was used to visualize the nucleus (blue).
Scale bars, 50 mm.
(B) As for (A) but for hippocampal neurons co-ex-
pressing Cav2.2-HA D122A with b1b and mCherry
in the presence (top row) or absence (bottom row)
of a2d-1.
(C) Bar chart (mean ± SEM) showing expression of
WT and D122A CaV2.2-HA, determined by both HA
staining prior to permeabilization (green bars) and
II-III loop staining after permeabilization (gray bars),
together with the expression marker mCherry. Data
for 197 (WT+a2d-1), 130 (WTa2d-1), 174 (D122A+
a2d-1), and 211 (D122A  a2d-1) neurites from
4 separate transfections in 2 experiments were
normalized to theWTCaV2.2-HA+a2d-1condition in
each experiment. ****p < 0.0001 (1-way ANOVA
comparedwithWTCaV2.2+a2d-1,withSidak’spost
hoc analysis correcting for multiple comparisons).
(D) Representative confocal images showing hip-
pocampal somata expressing CaV2.2-HA WT (top
two rows) or Cav2.2-HA D122A (bottom two rows)
together with b1b and mCherry in the presence
(top row) or absence (bottom row, control) of
a2d-1. Expression of mCherry is shown in red (first
panel). Cav2.2-HA (green, second panel) was
stained using rat anti-HA Ab in non-permeabilized
cells, and the rabbit II-III loop Ab (white, third
panel) after permeabilization. DAPI was used to
visualize the nucleus (blue), and the merged image
is shown in the fourth panel. Scale bars, 20 mm.
(E) Bar chart (mean ± SEM) showing expression of
WT and D122A CaV2.2-HA, determined by HA
staining prior to permeabilization (green bars), together with expression marker mCherry (red bars). Data for 32 (WT + a2d-1), 26 (WT - a2d-1), 37 (D122A + a2d-1),
and 35 (D122A  a2d-1) cell bodies from 4 separate transfections in 2 experiments were normalized to the WT CaV2.2-HA + a2d-1 condition in each experiment.
****p < 0.0001 (1-way ANOVA compared with WT CaV2.2 + a2d-1, with Sidak’s post hoc analysis correcting for multiple comparisons).b1b and either without a2d or plus either a2d-1 or Cachd1 (Fig-
ures 3E–3G), using a method described previously (Cassidy
et al., 2014). We found that Cachd1 reduced the endocytosis
rate of CaV2.2 (Figures 3E–3G). The mean endocytosis time con-
stant was increased from 8.5 min for CaV2.2 + b1b to 15.4 min in
the additional presence of Cachd1 (Figure 3F). This is unlike
a2d-1, which has no effect on CaV2.2 endocytosis (Cassidy
et al., 2014), a result confirmed here. This effect of Cachd1 on
endocytosis may therefore contribute to the increased cell sur-
face expression of CaV2.2.
TheD122AMutation Abolishes the Effect of a2d-1 on the
Trafficking of CaV2.2 into Cultured Hippocampal
Neurites
Because we have found the presence of a2d to be a key regu-
lator of trafficking of CaV2.2 into neuronal processes (Kadurinet al., 2016), we investigated whether the D122A mutation would
influence this. Cultured hippocampal neurons were transfected
after 7 days in culture, by which time there was already exten-
sive neurite outgrowth. All conditions included b1b and mCherry
as a control for successful transfection. After7 days of expres-
sion, as expected, WT CaV2.2-HA was strongly trafficked
into hippocampal neuronal processes when co-expressed
with a2d-1 (Figures 4A and S4C). In contrast, there was almost
no trafficking of D122A Cav2.2-HA into hippocampal neurites
when co-expressed with a2d-1 (Figures 4B and 4C). Its level
in the neurites was only 6% of that of WT CaV2.2-HA with
a2d-1 (Figure 4C). Similarly, staining the intracellular pool of
CaV2.2 using the II-III linker Ab showed that the level of D122A
CaV2.2-HA was only 13% of WT CaV2.2-HA (Figure 4C), further
indicating that the effect of a2d-1 is on trafficking CaV2.2 into the
neurites.Cell Reports 25, 1610–1621, November 6, 2018 1615
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Figure 5. Cachd1 Promotes CaV2.2-HA Dis-
tribution in Hippocampal Neurites
(A) Representative confocal images showing
neurites of hippocampal neurons expressing
CaV2.2-HA WT (left) or Cav2.2-HA D122A (right)
together with b1b andmCherry in the absence (top
row) or presence (bottom row) of Cachd1.
Expression ofmCherry is shown in red. Scale bars,
20 mm.
(B) Bar chart (mean ± SEM) showing neurite
expression of WT and D122A CaV2.2-HA, deter-
mined by HA staining of intact cells prior to per-
meabilization. Shown are data for 137 (WT, blue
solid), 144 (D122A, blue open), 200 (WT + a2d-1, red
solid), 111 (D122A + a2d-1, red open), 175 (WT +
Cachd1, green solid), and 152 (D122A + Cachd1,
green open) neurites from3experiments. Datawere
normalized to the WT CaV2.2-HA + a2d-1 condition
in each experiment. ****p < 0.0001, yp = 0.0473
between WT CaV2.2-HA + Cachd1 and D122A
CaV2.2-HA + Cachd1, #p = 0.5563 between D122A
CaV2.2-HAandD122ACaV2.2-HA+Cachd1 (1-way
ANOVAandSidak’spost hoc analysis correcting for
multiple comparisons).In the absence of a2d-1, there was almost no trafficking of WT
CaV2.2-HA into hippocampal neurites (Figures 4A and 4C). The
same was true for D122A CaV2.2-HA, its level being similar in
the presence and absence of a2d-1 (Figures 4B and 4C).
We also analyzed cell surface expression of CaV2.2 in the cell
bodies of these hippocampal neurons and found essentially the
same result; the increase in cell surface expression resulting
from a2d-1 was abrogated by the D122A mutation (Figures 4D
and 4E), although an intracellular signal was present for both
WT and D122A CaV2.2-HA (Figure 4D).
Cachd1 Increases the Trafficking of CaV2.2 into
Hippocampal Neurites
We therefore also investigated the effect of Cachd1 on trafficking
of CaV2.2-HA into hippocampal neurites (Figure 5A). We found
that it produced a consistent increase of WT CaV2.2-HA by
3.3-fold (Figures 5A and 5B), although this was less than the
6.8-fold increase produced by a2d-1 in the same experiment.
However, in this experimental context, Cachd1 was much less
able to traffic D122A CaV2.2-HA into neurites than WT CaV2.2-
HA (Figures 5A and 5B), unlike the result observed in the N2A
cell line. This result is in agreement with our previous finding
that trafficking of CaV2.2 ismore stringently controlled in neurons
than in cell lines (Kadurin et al., 2016).1616 Cell Reports 25, 1610–1621, November 6, 2018Cachd1 Competes with a2d-1 for
Interaction with CaV2.2
The preceding experiments indicate that
Cachd1 does not utilize the domain I
D122 interaction site on CaV2.2, which is
required by a2d-1 for interaction via its
MIDAS motif. Because Cachd1 still has
a VWA domain, albeit with a disrupted
MIDAS motif, we wondered whether
Cachd1 might potentially be an antago-nist at this site, interfering with the effect of a2d-1. We found
that Cachd1 concentration-dependently reduced the coIP of
a2d-1 with GFP_CaV2.2, by 71% when both cDNAs were trans-
fected in equal amounts (Figures 6A and 6B), indicating that
Cachd1 can obstruct the interaction site on CaV2.2 utilized by
a2d-1.
Furthermore, in experiments measuring CaV2.2 cell surface
expression (Figures 6C and 6E), the additional presence of
Cachd1 significantly reduced the effect of a2d-1 on cell surface
expression of CaV2.2-HA by 28.4% (Figure 6E, purple bar) but
had no effect on its intracellular expression (Figure 6F). In this
experiment, the increase in cell surface expression of CaV2.2-
HA in the presence of Cachd1 alone was 54.4% of the CaV2.2-
HA + a2d-1 level (Figure 6E, green bar), and this increase with
Cachd1 was still observed for D122A CaV2.2 (47.9% of the
CaV2.2 + a2d-1 level; Figure 6E, open green bar). The additional
presence of a2d-1 had no effect on the increase of D122A CaV2.2
cell surface expression in the presence of Cachd1 (Figure 6E,
open purple bar).
In a direct parallel with these results, we observed that Cachd1
co-expression significantly reduced CaV2.2 currents in the
presence of a2d-1, almost to the level of CaV2.2 currents in the
presence of Cachd1 alone (Figures 7A and 7B), but a2d-1 had




Figure 6. Cachd1 Competes with a2d-1 for
Interaction with CaV2.2
(A) IP of GFP_CaV2.2-HA and coIP of a2d-1 in the
absence of Cachd1 (left lane, 0; includes TASK3
cDNA as a control) or presence of 0.53 or 13
Cachd1 (center and right lanes, with 0.53 or no
TASK3 cDNA, respectively). See STAR Methods
for details regarding the cDNA mixes. Shown are
WCL input (left) and IP (right) for a2d-1 (top) and
GFP_CaV2.2-HA (bottom, detected with HA Ab).
The IP was performedwith GFP Ab. Co-IP of a2d-1
is shown at the top right (arrow).
(B) Scatterplot showing the effect of Cachd1 on
a2d-1 co-IP with GFP_CaV2.2-HA for 6 experi-
ments, including that in (A). Shown are no Cachd1
(red squares), 0.53 Cachd1 (purple half-closed
squares), and 13 Cachd1 (purple squares). Data
are the ratio of a2d-1 in IP/input, normalized to no
Cachd1 in each experiment. Mean and SEM are
also shown; *p = 0.0144, **p = 0.0021 (1-way
ANOVA with repeated measures and Sidak’s post
hoc test with multiple comparisons correction,
comparing +Cachd1 to no Cachd1).
(C and D) Representative confocal images of N2A
cells expressing CaV2.2-HA WT (C) or D122A (D)
with b1b in the presence of a2d-1 (top row),
rCachd1 (center row), or both a2d-1 and rCachd1
(bottom row). Intact cells (non-permeabilized)
were incubated with rat anti-HA Ab for 1 hr to show
extracellular HA staining on the plasmamembrane
(left, green). The cells were then permeabilized and
stained with the CaV2.2 II-III loop Ab (center, red).
Merged images are shown on the right; DAPI was
used to stain the nuclei (blue). Scale bars, 20 mm.
(E and F) Bar charts showing cell surface expres-
sion of WT (closed bars) and D122A CaV2.2-HA
(open bars), determined by HA staining prior to
permeabilization (E), and cytoplasmic expression
determined by II-III loop staining after per-
meabilization (F). CaV2.2 with a2d-1 is shown in
red, with rCachd1 in green, and with both a2d-1
and rCachd1 in purple. Data for 328 (WT + a2d-1),
255 (WT + rCachd1), 231 (WT + both), 272
(D122A + a2d-1), 270 (D122A + rCachd1), and 225
(D122A + both) cells from 3 experiments were
normalized to theWTCaV2.2-HA + a2d-1 condition
in each experiment. ****p < 0.0001, yp < 0.0001
versus WT, #p = 0.005 versus WT (1-way ANOVA
with Sidak’s post hoc test, comparing all columns
and correcting for multiple comparisons).currents (Figures 7C and 7D). Interestingly, when a2d-1 and
Cachd1 were co-expressed, the reversal potential for WT
CaV2.2 currents was identical to that observed with a2d-1 alone
(Figure 7E), pointing to preferential a2d-1 interaction on the cell
surface. By contrast, for D122A CaV2.2 currents, the reversal po-
tential in the presence of both a2d-1 and Cachd1 was similar to
that for Cachd1 alone (Figure 7F), reinforcing the evidence for
a lack of interaction of this mutant with a2d-1.
DISCUSSION
In this study, we uncovered a mechanism for influencing CaV2.2
channel trafficking and function mediated by the a2d-like proteinCachd1, despite its VWA domain having a disrupted MIDAS
motif.
We first established the importance of interaction of CaV2.2
with the a2d-1 VWA domain for its cell surface expression and
function by mutating the predicted a2d interaction site in
CaV2.2 (D122), which is in the first extracellular loop of domain
I. This mutation completely abolished the ability of a2d-1 to in-
crease the trafficking of CaV2.2 and to increase CaV2.2 currents,
indicating that it is the main interaction site between the channel
and a2d. This was confirmed by our coIP results.
Surprisingly, Cachd1 consistently produced a 4.5-fold in-
crease in CaV2.2 currents and also increased the cell surface




Figure 7. Cachd1 Competes with a2d-1 for
Effects on CaV2.2 Currents
(A) Mean (± SEM) current-voltage relationships for
WT CaV2.2-HA co-expressed with b1b and either
a2d-1 (red solid circles, n = 25), Cachd1 (green
solid circles, n = 18), or a2d-1 and Cachd1 (purple
solid circles, n = 18). The individual and mean data
were fit with amodified Boltzmann equation (STAR
Methods).
(B) Gmax (nS/pF) from the current-voltage re-
lationships shown in (A). Individual data (same
symbols as in A) and mean ± SEM are plotted.
*p = 0.0483, **p = 0.0086 (1-way ANOVA with
Holm-Sidak’s post hoc test correcting for multiple
comparisons).
(C) Mean (± SEM) current-voltage relationships for
D122A CaV2.2-HA co-expressed with b1b and
either a2d-1 (red open circles, n = 10), Cachd1
(green open circles, n = 8), or a2d-1 and Cachd1
(purple open circles, n = 12).
(D) Gmax (nS/pF) from the current-voltage re-
lationships shown in (C). Individual data (same
symbols as in C) and mean ± SEM are plotted.
*p = 0.0342, yp = 0.0265 (1-way ANOVA with
Holm-Sidak’s post hoc test correcting for multiple
comparisons).
(E and F) Bar charts of mean (± SEM) Vrev (millivolt)
for the conditions shown in (A) and (C), respec-
tively. *p = 0.0396, **p = 0.0088, ***p = 0.0002,
****p < 0.0001 (1-way ANOVA with Holm-Sidak’s
post hoc test correcting for multiple comparisons).subunits, neither the trafficking effects of Cachd1 in N2A cells
nor its effect on calcium channel currents were affected by
the presence of the D122A mutation in CaV2.2. Therefore, these
effects of Cachd1 are likely not to be mediated via its disrupted
MIDAS motif but, rather, due to interactions of the Cache or
other domains in the protein. Interestingly, our results indicate
that the effect of Cachd1 on cell surface expression of CaV2.2
involves a reduction in CaV2.2 endocytosis. It is highly unlikely
that this is a non-specific effect because we have previously
provided many examples of protein constructs that do not in-
crease CaV2.2 currents or cell surface expression (Ferron
et al., 2008; Kadurin et al., 2016, 2017; Macabuag and Dolphin,
2015).
In a2d-1 and a2d-2, the key MIDAS motif in the VWA domain
contains three polar or negatively charged residues and has
the sequence DVSGS. It is these three residues (D259, S261,1618 Cell Reports 25, 1610–1621, November 6, 2018and S263 in rat a2d-1 used here), plus
two others (T331 and D363) in separate
loops of the VWA domain that, together
with the VWA protein ligand (CaV2.2 in
this study), coordinate a divalent cation.
In a2d-3 and a2d-4, one of these other
coordinating residues is non-polar, but
the MIDAS motif is intact. We confirm
here that the increase in CaV2.2 currents
caused by a2d-3 is also abolished by the
D122Amutation in CaV2.2. A similar result
was found for the interaction of CaV1.2with a2d-1 in an extensive site-directed mutagenesis study
(Bourdin et al., 2017).
By contrast, Cachd1 contains a VWA domain that has a dis-
rupted MIDAS motif (DHGAS), a sequence that is conserved in
the human, rat, mouse, and zebrafish Cachd1 proteins. This
conservation across species supports the possibility that it
may retain some function. Indeed, the ability of Cachd1 to in-
crease the trafficking of CaV2.2 into hippocampal neurites
was significantly reduced for D122A CaV2.2, suggesting that
the disrupted MIDAS motif in Cachd1 may play some role in
the interaction required for CaV2.2 trafficking into neurites.
This result also indicates that there may be more stringent traf-
ficking requirements for this channel in neurons. We drew a
similar conclusion in a previous study, in which we showed
that immature pro-a2d-1 could traffic CaV2.2 to the cell surface
in non-neuronal cells but not into hippocampal neurites, where
mature proteolytically processed a2d-1 was required (Kadurin
et al., 2016).
We have shown previously that, when the three polar or
charged residues of the a2d-1 MIDAS motif are mutated to
alanine, a2d-1 still associates with CaV2.2, as judged by its ability
to occlude antigenic epitopes within the Cache domains of a2d-1
(Cassidy et al., 2014), although it fails to promote CaV2.2 traf-
ficking. This indicates that there are certainly additional interac-
tion sites as well as the MIDAS site interaction between a2d-1
and CaV2.2. The cryo-EM structure of the skeletal muscle cal-
cium channel complex indicates clearly that a2d-1 interacts
with CaV1.1 via multiple sites in addition to the divalent cation-
mediated VWA domain interaction, including an interaction of a
Cache domain with the turret of pore loop 5 in domain III (Wu
et al., 2016). Such an interaction with the pore domain of
CaV2.2 could also potentially explain the effect of Cachd1 on
the apparent reversal potential. Because Cachd1 was able to
coIP CaV2.2, partially co-localized with CaV2.2 on the cell sur-
face of transfected cells, and also affected the reversal potential
of these channels, it is clear that Cachd1 is not solely a trafficking
protein but influences functional channels in the plasma mem-
brane. The influence of another protein on the reversal potential
of a channel, interpreted as an effect on its selectivity filter, has
been observed previously (Stephan et al., 2018). The lack of ef-
fect of Cachd1 on CaV2.1 currents may relate to a particular
splice variant or be common to all isoforms of CaV2.1 and should
allow us to localize the site of selective interaction of Cachd1with
CaV2.2 in the future.
The finding that Cachd1 was able to inhibit the co-IP between
CaV2.2 and a2d-1 and reduce the effect of a2d-1 on CaV2.2 cell
surface expression and CaV2.2 currents indicates that, in vivo,
it could play either a positive or an inhibitory role on CaV2.2 cur-
rents, depending on the degree of association of the CaV2.2
channels with a2d. From mRNA expression screens, Cachd1 is
widely expressed in many tissues, including the brain, lungs,
and small intestine. Of particular interest here is that Cachd1
mRNA expression was highest in dorsal root ganglia of all mouse
tissues examined (see the transcriptome database described in
Ray et al., 2018), raising the intriguing possibility that Cachd1
may modulate the efficacy of a2d-1 following neuropathic injury,
a hypothesis that we will investigate in future studies.
Within the brain, there is strong expression of a2d-1 mRNA in
the mouse hippocampus (Schlick et al., 2010). It is expressed
strongly in CA1 and also present in dentate granule neurons.
Cachd1 mRNA is also expressed in the mouse hippocampus,
and, within the pyramidal cell layer, it is particularly prominent
in CA3 but also in CA1 (Allen Mouse Brain Atlas; mouse.brain-
map.org/api/index.html). Thus, Cachd1 and a2d-1 are likely to
be expressed in overlapping cell types in the hippocampus.
Within the rat hippocampus, there is a robust signal for a2d-1
protein in synaptic regions, including the dentate gyrus molecu-
lar layer, the stratum lucidum of CA3, and the CA1 stratum oriens
and stratum radiatum (Nieto-Rostro et al., 2014; Taylor and Gar-
rido, 2008); however, there are no equivalent data available for
Cachd1 because of the paucity of antibodies and lack of
knockout control tissue. Furthermore, in a large-scale proteomic
study of non-neuronal cell lines, several proteins interacting with
Cachd1 have been described recently (Huttlin et al., 2017); thissuggests other potential roles for this protein in non-excitable
cells (Rutledge et al., 2017).
In the future, it will be of great interest to determine the effect of
Cachd1 on native calcium channels and whether its expression
is altered in conditions such as neuropathic injury of primary
afferent neurons to further elucidate its physiological role and
to understand whether it competes endogenously with a2d-1 or
other a2d subunits.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell lines
Cell lines were plated onto cell culture flasks, coverslips coated with poly-L-lysine, and cultured in a 5% CO2 incubator at 37
C.
tsA-201 cells (ECACC, female sex) were cultured in Dulbecco’s modified Eagle’s medium in the presence of 10% fetal bovine serum,
penicillin, streptomycin and 2% GlutaMAX (Invitrogen). N2A cells (ATCC, male sex) used for immunocytochemistry experiments,
were cultured in DMEM and OPTI-MEM (1:1), supplemented with FBS (5%), penicillin (1 unit/ml), streptomycin (1 mg/ml), and
GlutaMAX (1%).
Primary Hippocampal cultures
Hippocampal neurons were obtained from P0 rat pups (Sprague-Dawley, male), as previously described (Morales et al., 2000). All
experiments were performed in accordance with the UK Home Office Animals (Scientific procedures) Act 1986, using a Schedule
1 method, with UCL ethical approval. Briefly, hippocampi were dissected and treated for 40 min at 37C with a papain solution
containing: 70 units /ml of papain, 0.2mg/ml L-cysteine, 0.2mg/ml bovine serum albumin (BSA), 1mg/ml DNase and 5mg/ml glucose
(all from Sigma Aldrich) in Hank’s basal salt solution (HBSS) medium (Invitrogen). Hippocampi were then washed twice with plating
solution (Neurobasal medium supplemented with B27 (Thermo Fisher Scientific; 2%), HEPES (10 mM), horse serum (5%), glutamine
(0.5 mM) and 1 unit/ml penicillin, 1 mg/ml streptomycin), and the neurons were mechanically dissociated using fire-polished glass
Pasteur pipettes with decreasing diameter. Approximately 75 3 103 cells in 100 ml of plating solution were seeded onto sterile
poly-lysine-coated glass coverslips. After 2 h, the plating solution was replaced with 1 ml of growth medium (serum-free Neurobasal
medium supplemented with B27 (4%), 2-mercaptoethanol (25 mM), glutamine (0.5 mM), and 1 unit/ml penicillin, 1 mg/ml strepto-
mycin), half of which was replaced every 3-4 days. At 7 days in vitro and 2 h before transfection, half of the medium was removed,
and kept as ‘conditioned’ medium, and 500 ml of fresh medium was added.
METHOD DETAILS
Molecular biology and constructs
cDNAs encoding the following proteins were used: calcium channel CaV2.2 (rabbit, GenBank: D14157), containing an extracellular
HA tag (Cassidy et al., 2014), b1b (rat, GenBank: X61394), a2d-1 (rat, GenBank: M86621), HA-tagged a2d-1 (Kadurin et al., 2012), rat
Cav2.1 (GenBank:M64373), human TASK3 (KCNK9) cDNA (GenBank: NM_001282534) andmCherry. Zebrafish zCachd1was cloned
from a zebrafish cDNA library. Rat rCachd1 cDNA (GenBank: NM_001191758) was purchased from OriGene. Note that the Cachd1
gene was misnamedCacna2d4 in the original bioinformatics paper in which it was identified as a2d-like (Whittaker and Hynes, 2002).
All cDNAs were subcloned into the expression vectors pMT2, pcDNA3 and pCAGGS. In some experiments, CaV2.2-HA also had the
green fluorescent protein, mut3bGFP (GFP), fused to the N terminus (Macabuag and Dolphin, 2015). The D122A mutation was intro-
duced into CaV2.2 by mutating aspartate at position 122 of rabbit CaV2.2 to alanine by PCR. C-terminal GFP fusion proteins of both
zCachd1 and rCachd1 were made by standard techniques, and used where stated. The sequences of all constructs were confirmed
by DNA sequencing.
Antibodies and other materials
Ca channel Abs used were: a2d-1 Ab (mouse monoclonal against a2-1 moiety, Sigma-Aldrich, epitope identified in (Cassidy et al.,
2014)), anti-CaV2.2 II-III loop Ab (rabbit polyclonal) (Raghib et al., 2001). A bespoke, affinity-purified Cachd1 rabbit polyclonal Ab
was raised by Cambridge Research Biochemicals (Billingham, UK) against the predicted extracellular domain of zCachd1 protein,
produced by transient transfection of mammalian cells (Durocher et al., 2002) (G.T.P., S.W.W., and Gavin J. Wright, unpublished
data). Purified Ab activity was confirmed by enzyme-linked immunosorbent assay. Other Abs used were anti-HA (rat monoclonal,
Roche), anti-HA (rabbit polyclonal, Sigma), anti-GAPDH Ab (mouse monoclonal, Ambion), and GFP Ab (Living Colors, rabbit poly-
clonal; BD Biosciences). For immunocytochemistry, secondary Abs (1:500) used were anti-rabbit-Alexa Fluor 594, anti-rat-Alexa
Fluor 488, anti-mouse-Alexa Fluor 647 (Life Technologies) or anti-rat fluorescein isothiocyanate (Sigma-Aldrich). The secondary
Abs used for Western Blotting were goat anti-rabbit, goat anti-rat, and goat-anti-mouse Abs coupled to horseradish peroxidase
(HRP) (Biorad). u-conotoxin GVIA was purchased from Alomone, and applied by local perfusion.
Cell line transfection
For co-IPs and electrophysiological studies, tsA-201 cells were transfected using Fugene6 (Promega, Fitchburg,WI) according to the
manufacturer’s protocol. For immuno-cytochemistry, tsA-201 cells were transfected using PolyJet (SignaGen) according to theman-
ufacturer’s protocol. N2A cells were re-plated onto poly-lysine coated coverslips and transfections were carried out using PolyJete3 Cell Reports 25, 1610–1621.e1–e5, November 6, 2018
(SignaGen) at a ratio of 3:1 to DNA mix according to manufacturer’s instructions. For all electrophysiology and imaging experiments
transfections, the cDNAmix consisted of cDNAs encodingWT or D122ACaV2.2, b1b, a2d-1 in a ratio of 3:2:2. The a2d-1 was replaced
with Cachd1 or empty vector where appropriate. When these experiments involved both a2d-1 and Cachd1, CaV2.2, b1b, a2d-1 and
Cachd1 were added in a ratio of 3:2:2:2, with empty vector replacing a2d-1 or Cachd1 where appropriate. For co-IP experiments
CaV2.2 (with or without GFP and HA tags, as stated), b1b and a2d-1 were transfected in a ratio of 2:1:2. For co-IP competition
experiments the transfection mix contained CaV2.2: b1b: a2d-1: (TASK3, Cachd1 or a 1:1 mix of both) in a ratio of 2:1:2:1. For reverse
co-IP experiments, Cachd1_GFP, b1b, and CaV2.2 were transfected in a ratio of 2:1:2.
Neuronal transfection
The hippocampal cultures were then transfected using Lipofectamine 2000, at a ratio of 1:2 to DNAmix (1 mg/ml). After 2 h, the trans-
fection mixes were replaced with growth medium consisting of 50% conditioned and 50% fresh medium. The DNA mix consisted of
cDNAs in pCAGGS encoding WT CaV2.2 or D122A CaV2.2, a2d-1, b1b and mCherry, at a ratio of 3:2:2:0.5. a2d-1 was replaced by
empty vector or rCachd1 when appropriate.
Cell surface biotinylation, cell lysis, deglycosylation and immunoblotting
The procedures were modified from those described in more detail previously (Kadurin et al., 2012; Kadurin et al., 2016). Briefly, 72 h
after transfection, tsA-201 cells were incubated for 30 min at room temperature with 0.5 mg/ml Premium Grade EZ-link Sulfo-NHS-
LC-Biotin (ThermoScientific) in PBS and the reactionwas quenchedwith 200mMglycine. The cells were resuspended in PBS, pH 7.4
at 4C containing 1% Igepal; 0.1% SDS and protease inhibitors (PI, cOmplete, Roche), to allow cell lysis, cleared by centrifugation at
18,0003 g and assayed for total protein (Bradford assay, Biorad). ClearedWCL corresponding to 20 – 40 mg total protein was mixed
with Laemmli sample buffer (Davies et al., 2010) supplemented with 100mMdithiothreitol (DTT), resolved by SDS-polyacrylamide gel
electrophoresis (PAGE) on 3%–8% Tris-Acetate (Invitrogen) and transferred to polyvinylidene fluoride (PVDF) membrane (Biorad).
The proteins were revealed by immunoblotting performed with the corresponding Abs essentially as described previously (Kadurin
et al., 2012). The signal was obtained by HRP reaction with fluorescent product (ECL 2; Thermo Scientific) and membranes were
scanned on a Typhoon 9410 phosphorimager (GE Healthcare). Biotinylated lysates (equalized to between 0.5 and 1 mg/ml total pro-
tein concentration) were applied to 40 ml prewashed streptavidin-agarose beads (ThermoScientific) and rotated overnight at 4C. The
beads were then washed 3 times with PBS containing 0.1% Igepal and, when required, the streptavidin beads were deglycosylated
for 3 h at 37C with 1 unit of PNGase F (Roche Applied Science). The samples containing precipitated cell surface protein fractions
were then analyzed by immunoblotting with the indicated Abs as described previously (Kadurin et al., 2012).
Co–Immunoprecipitation
The protocol described belowwas adapted from a procedure described previously (Gurnett et al., 1997). A tsA-201 cell pellet derived
from one confluent 75 cm2 flask was resuspended in co-IP buffer (20 mM HEPES (pH 7.4), 300 mM NaCl, 1% Digitonin and PI), son-
icated for 8 s at 20 kHz and rotated for 1 h at 4C. The samples were then diluted with an equal volume of 20 mM HEPES (pH 7.4),
300 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, with PI (to 0.5% final concentration of Digitonin), mixed by pipetting and centrifuged at
20,000 x g for 20 min. The supernatants were collected and assayed for total protein (Bradford assay; Biorad). 1 mg of total protein
was adjusted to 2mg/ml with co-IP buffer and incubated overnight at 4Cwith anti-GFP polyclonal Ab (1:200; BD Biosciences). 30 ml
A/G PLUS Agarose slurry (Santa Cruz) was added to each tube and further rotated for 2 h at 4C. The beads were then washed three
times with co-IP buffer containing 0.2% Digitonin. The beads were then resuspended in 2 x Laemmli buffer with 100 mM DTT and
analyzed alongside equalized aliquots of the initial lysate prior to co-IP by SDS-PAGE and western blotting as described above.
The reverse co-IP experiments between Cachd1_GFP and CaV2.2-HA were performed under identical conditions except that the
NaCl concentration in the co-IP buffer was 150mM, and the beads were washed two times in co-IP buffer containing 0.1%Digitonin.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS, pH 7.4) for 5 min, incubated with blocking buffer
(20% goat serum, 4% BSA in PBS) for 1 h at room temperature before being incubated with rat anti-HA (Roche) diluted 1:200 in
0.5x blocking buffer for 1 h at room temperature. When permeabilization was included, cells were permeabilized with 0.2% Triton
X-100 for 5 min before being incubated with the second primary Ab, rabbit anti-CaV2.2 II-II loop (1:250), for 1 h at room temperature.
For hippocampal neurons, primary Ab incubation was carried out at 4C overnight. After washing, samples were incubated with
secondary Abs, anti-rat Alexa Fluor 488, anti-rat Alexa Fluor 594 and anti-rabbit Alexa Fluor 488, at a dilution of 1:500 for 1 h at
room temperature. 4’,6-diamidine-20-phenylindole dihydrochloride (DAPI) was used to visualize the nuclei. Coverslips were washed
and mounted in VectaShield (Vector Laboratories).
Endocytosis assay
N2A cells were transfected with a CaV2.2 construct tagged with a double bungarotoxin binding site epitope (CaV2.2-BBS) (Cassidy
et al., 2014), b1b and either empty vector, a2d-1 or rCachd1. After 40 h expression, cells were washed twice with Krebs-Ringer
solution with HEPES (KRH) (in mM; 125 NaCl, 5 KCl, 1.1 MgCl2, 1.2 KH2PO4, 2 CaCl2, 6 Glucose, 25 HEPES, 1 NaHCO3) and
incubated with 10 mg/ml a-bungarotoxin Alexa Fluor 488 conjugate (BTX-488) (Thermo Fisher Scientific) at 17C for 30 min. TheCell Reports 25, 1610–1621.e1–e5, November 6, 2018 e4
unbound BTX-488 was removed by washing with KRH, and the labeled cells were returned to 37C for the kinetic assay. Endocytosis
was terminated by fixing the cells with cold 4% PFA-sucrose in PBS at the specified time. The cells were then permeabilized and
intracellular CaV2.2 was labeled using the rabbit anti-CaV2.2 II-III loop Ab as described above.
Image Analysis
N2A and tsA-201 cell samples were viewed on an LSM 780 confocal microscope (Zeiss) using either 63x/1.4 or 40x/1.3 numerical
aperture oil-immersion objective in 16-bit mode. The tile function (3x3 tiles, each tile consisting of 1024x1024 pixels) was used
and every transfected cell within the image was analyzed to remove collection bias. Hippocampal neurons were viewed using a
20x objective (neuronal processes) or 63x objective (soma); individual neurons were selected on the basis of mCherry expression.
Acquisition settings, chosen to ensure that imageswere not saturated, were kept constant for each experiment. Images are individual
optical sections, unless otherwise stated.
Imageswere analyzed using ImageJ (National Institutes of Health). For N2A cells, the freehand line tool (5 pixels) was used tomanu-
ally trace the plasmamembrane to measure the mean intensity of cell-surface staining. Intracellular staining was measured using the
freehand selection tool, excluding the nucleus and the plasmamembrane. For hippocampal neurons, two concentric circles (100 and
150 mmdiameter) were centered on the soma and the freehand line tool (3 pixels) was used to trace the neuronal processes between
the circles, using the mCherry image as the template. The background fluorescence was measured in an area with no transfected
cells and subtracted from the mean intensity.
Electrophysiology
Calcium channel currents in transfected tsA-201 cells were investigated by whole cell patch-clamp recording. The patch pipette
solution contained in mM: Cs-aspartate, 140; EGTA, 5; MgCl2, 2; CaCl2, 0.1; K2ATP, 2; HEPES, 10; pH 7.2, 310 mOsm with sucrose.
The external solution for recording Ba2+ currents contained in mM: tetraethylammonium (TEA) Br, 160; KCl, 3; NaHCO3, 1.0; MgCl2,
1.0; HEPES, 10; glucose, 4; BaCl2, 1, pH 7.4, 320 mOsm with sucrose. 1 mM extracellular Ba
2+ was the charge carrier. Pipettes of
resistance 2-4 MU were used. An Axopatch 1D or Axon 200B amplifier was used, and whole cell voltage-clamp recordings were
sampled at 10 kHz frequency, filtered at 2 kHz and digitized at 1 kHz. 70%–80% series resistance compensation was applied,
and all recorded currents were leak subtracted using P/8 protocol. Membrane potential was held at – 80mV. Analysis was performed
using pCLAMP 9 (Molecular Devices) and Origin 7 (Microcal Origin, Northampton, MA). IV relationships were fit by a modified Boltz-
mann equation as follows: I = Gmax*(V-Vrev)/(1+exp(-(V-V50, act)/k)) where I is the current density (in pA/pF), Gmax is the maximum
conductance (in nS/pF), Vrev is the apparent reversal potential, V50, act is the midpoint voltage for current activation, and k is the slope
factor.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were analyzed with GraphPad Prism 7 (GraphPad software, San Diego, CA) or Origin-Pro 2015 (OriginLab Corporation, North-
ampton, MA, USA). All data are shown as mean ± SEM; ‘‘n’’ refers to number of cells or neurites, unless indicated otherwise, and is
given in the figure legends, together with details of statistical tests used. Experiments where representative data are shown were
repeated at least 3 times, unless otherwise stated. Graphpad Prism 7 was used for statistical analysis. Statistical significance
between two groups was assessed by Student’s t test, as stated. One-way ANOVA and the stated post hoc analysis was used
for comparison of means between three or more groups.e5 Cell Reports 25, 1610–1621.e1–e5, November 6, 2018
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SUPPLEMENTARY FIGURES 
Figure S1 (relates to Figure 1):  Cachd1 is a membrane protein and sequence of rat Cachd1 showing 
predicted N-glycosylation sites.   
 
 
(A) Sequence of rCachd1.  Highly predicted N-glycosylation NxS/T sequences are shown in red, sequences 
with a sub-threshold prediction level are in blue.  The approximate predicted position of the N-terminal 
signal sequence is underlined, and the approximate predicted position of the transmembrane segment is 
underlined in green.  Predictions are from Signal P4.1, NetNglyc 1.0 and ExPASy TMpred. 
(B) Representative confocal images of tsA-201 cells expressing CaV2.2 HA WT (left) with β1b and zCachd1.  
Cells were permeabilized, and incubated with rat anti-HA and rabbit anti-Cachd1 Abs for 1 h to show 
distribution of HA staining (left panel, red) and Cachd1 (middle panel, green).  Merged images (with co-
localization in yellow) are shown in the right-hand panel; DAPI was used to stain the nuclei (blue).  Scale 
bars are 20 µm.   
(C)  WCL input for experiment shown in Figure 1G, blotted with Cachd1 Ab.  zCachd1_GFP (left lane) and 
untagged zCachd1 (right lane).  The Cachd1 Ab shows two bands for both species, whereas the GFP Ab 
shows a single band for zCachd1_GFP (Figure 1G), indicating that the lower band (which is the same MW 
in both lanes) is a cleavage product containing the N-terminus of the protein. 
(D)  WCL input (left panels) and IP (right panels) for WT and D122A mutant GFP_CaV2.2, and untagged 
CaV2.2 control (upper panels), and for rCachd1 (lower panels).  IP was performed with GFP Ab, and pulled 
down both WT and D122A GFP_CaV2.2 (upper right panel).  Lack of co-IP of Cachd1 is shown in lower right 
panel.  Representative of 3 experiments.  
  
Figure S2 (relates to Figure 2):  Effect of D122A mutation of CaV2.2 on CaV2.2 currents 
enhancement by α2δ-3 
 
 
(A)  Example families of CaV2.2 currents for WT CaV2.2-HA (left two) and D122A CaV2.2-HA (right 
two), co-expressed with β1b and either no α2δ (left), α2δ-3 (right).  Holding potential -80 mV, steps 
between -50 and +60 mV for 50 ms.  Calibration bars apply to all traces. 
(B)  Mean (± SEM) current-voltage relationships for the conditions shown in (A).  WT CaV2.2-HA (solid 
circles) and D122A CaV2.2-HA (open circles), co-expressed with β1b and either no α2δ (blue) or α2δ-3 
(red).  The individual and mean data were fit with a modified Boltzmann equation (see Methods).  
(C)  Gmax (nS/pF) from the current-voltage relationships shown in (B).  Individual data (same symbols 
as B) and mean ± SEM are plotted. ****P<0.0001.  
  
Figure S3 (relates to Figure 2G):  Cachd1 does not increase CaV2.1 currents  
 
 
(A)  Example current traces of CaV2.1 co-expressed with β1b and either no α2δ (left), α2δ-1 (middle) or 
Cachd1 (right).  Holding potential -80 mV, steps between -50 and +60 mV for 50 ms. 
(B) Maximum conductance Gmax (nS/pF) from the current-voltage relationships shown in Figure 2G.  
Individual data for CaV2.1 co-expressed with β1b and either no α2δ (blue solid circles), α2δ-1 (red solid 
circles) or Cachd1 (green solid circles) and mean ± SEM are plotted.  ns, not significant; **** P<0.0001 (one 
way ANOVA and Sidak’s post-hoc test correcting for multiple comparisons).  A similar result was observed 
for zCachd1 (data not shown). 
  
  




(A) Representative confocal images of tsA-201 cells expressing GFP_CaV2.2-HA WT with β1b in the 
absence of α2δ (control, top row) with α2δ-1 (middle row) or zCachd1 (bottom row).  Cells were not 
permeabilized and incubated with rat anti-HA antibody for 1 h to show extracellular HA staining on the 
plasma membrane (left panels, white), to be compared with intracellular GFP fluorescence (middle 
panels).  Merged images (with HA in red) are shown in the right-hand panels; DAPI was used to stain the 
nuclei (blue).  Scale bars are 50 µm. 
(B) Bar chart showing cell surface expression of CaV2.2-HA, determined by HA staining in the absence 
of permeabilization.  Control condition without α2δ or zCachd1 (blue, normalized to 100%), with α2δ-
1 (red) and zCachd1 (green).  Data for 901 (- α2δ-1), 921 (+ α2δ-1), 970 (+ zCachd1) cells were 
normalized to the CaV2.2-HA condition in each experiment. **** P<0.0001 (1-way ANOVA and 
Sidak’s post-hoc test correcting for multiple comparisons). 
